Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...

CAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (“Walden”), a private, venture-backed biotechnology company advancing disease-modifying therapies to transform the ...

Dr. LeBlanc, who has decades of experience transforming ... thousands of professionals across the industry," said Laura Ipsen, President and CEO, Ellucian. "His transformative work harnessing ...

"Dr. LeBlanc's visionary leadership has redefined ... inspire thousands of professionals across the industry," said Laura Ipsen, President and CEO, Ellucian. "His transformative work harnessing ...

She has served on the boards of Suez, Altran (now CapGemini), and Ipsen Pharmaceuticals. Dr. Crawford has also taught at Harvard Business School, where she developed and taught award-winning courses ...

TV personality and actor Dr Ranj Singh has gone Instagram official with his new boyfriend, actor and podcast host James Colebrook. Singh rang in the New Year by sharing the update with his near ...

Dr Disrespect took aim at “backstabbing” friends in an end-of-year post on X, where he alluded to the fallout that took over social media after the reason for his Twitch ban was revealed ...

Ipsen has joined the ranks of companies working on T cell receptor (TCR) therapies for cancer, paying $45 million upfront for rights to early-stage candidates developed by US biotech Marengo ...

Furthermore, the outbreak has the potential to transcend regional boundaries, particularly as DR Congo shares porous borders with Angola, where provinces such as Uige are vulnerable to cross-border ...

Grammy winner Dr. Dre has 10 children: Curtis, LaTanya, Tyra, LaToya, Ashley, Andre Jr., Marcel, Tyler, Truice and Truly Nicole Briese is a contributing writer at PEOPLE. She has been working at ...

Ipsen and Servier's hopes of extending the uses for chemotherapy drug Onivyde have been knocked back by a failed phase 3 trial of the drug as a second-line therapy for small cell lung cancer (SCLC).